Beta Glucan Market Size To Reach $1,195.7 Million By 2033

Beta Glucan Market Growth & Trends

The global beta glucan market size is expected to reach USD 1,195.7 million by 2033, registering a CAGR of 7.5% from 2026 to 2033, according to a new report by Grand View Research, Inc. The industry is anticipated to grow, primarily on account of its increased application in industries, including nutraceutical, functional food and pharmaceutical.

The consumers in the industry lay high emphasis on the source of the product. In addition, the overall quality is generally determined by the consumers through the certifications associated with the product. The industry is characterized by the presence of a notable regulatory framework with regulations related to processing, packaging, and transportation of the product.

Manufacturers are inclined toward use of innovative extraction methods such as AME, dry fractionation to increase the concentration of bioactive ingredients in the extract in an attempt to increase the customer base. Rising number of groceries, retail stores, and supermarkets offering the products are expected to trigger the industry growth.

There is an upsurge in the usage of seaweed for the extraction process with heavy investment noted by the companies which is anticipated to drive the industry growth over the forecast period. Mushroom is known to have more than 30 varieties, and is available in abundance across the globe, thereby benefitting the industry.

 Request a free sample copy or view report summary: Beta Glucan Market Report

Beta Glucan Market Report Highlights

• Yeast sourced beta-glucan is expected to be the fastest-growing segment, in terms of revenue, registering a CAGR of 7.8% from 2026 to 2033. Baker’s yeast is a widely used source for the product on account of its economical availability

• Insoluble product segment is expected to exhibit a CAGR of 8.4%, in terms of volume, on account of high demand for the product for use as an ingredient in the nutraceutical industry and pharmaceutical formulations. Insoluble forms of the product are largely consumed as a purgatory drug owing to its property in drug formulations

• The industry in Asia Pacific is anticipated to exhibit the fastest growth, registering a CAGR of 10.9% from 2026 to 2033 on account of rising awareness among population towards the consume naturally sourced pharmaceutical preparations

• The industry is exhibiting a high growth potential, due to which key players are focused towards the development of advanced formulations in that provide superior health benefits in a bid to cash in on the rapidly developing market

Beta Glucan Market Segmentation

Grand View Research has segmented the global beta glucan market based on product, application, source, and region:

Beta Glucan Product Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)

• Soluble

• Insoluble

Beta Glucan Application Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)

• Food & Beverage

• Cosmetics & Personal Care

• Pharmaceuticals

• Animal Feed

• Other Applications

Beta Glucan Source Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)

• Cereal

• Mushroom

• Yeast

• Seaweed

Beta Glucan Region Outlook (Volume, Kilotons; Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

• Asia Pacific

  • China

  • India

  • Japan

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia.

List of Key Players of Beta Glucan Market

• Biotec Pharmacon ASA

• Biothera Pharmaceuticals

• Ceapro Inc.

• Immunomedics

• Super Beta Glucan Inc.

• DSM NV

• Tate & Lyle Plc (Tate & Lyle Oat Ingredients)

• Groupe Soufflet SA (AIT Ingredients)

• Zilor Inc (Biorigin)

• Cargill Incorporated

• Frutarom

• GlycaNova AS

• Lesaffre Human Care

• Garuda International, Inc.

• Millipore Sigma